30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,186 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
DE Sartorius AG (SRT)
Healthcare Services Large (13.7bn) 0 Aucune activité — 50%+
US DaVita Inc (DVA)
Healthcare Services Large (13.7bn) -6–10 -$100M+ -0–15% 50%+
Pharmaceuticals & Medical Research Large (13.5bn) 0 Aucune activité — 50%+
Healthcare Services Large (13.5bn) 0 Aucune activité — 15–50%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.3bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (13.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (12.9bn) 0 Aucune activité — 50%+
Healthcare Services Large (12.9bn) 0 Aucune activité — 15–50%
Healthcare Services Large (12.9bn) 0 Aucune activité — 15–50%
US Penumbra Inc (PEN)
Healthcare Services Large (12.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (12.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (11.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (11.5bn) -1–5 -$100K–$1M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.5bn) 0 Aucune activité — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (11.2bn) 0 Aucune activité — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (11.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (10.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (10.5bn) -1–5 -$1M–$10M -0–15% 0–15%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 Aucune activité — 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (10.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (10.0bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
US Nuvalent Inc (NUVL)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (9.6bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (9.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 Aucune activité — 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.3bn) -6–10 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (9.3bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (8.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (8.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (8.9bn) 0 Aucune activité — 0–15%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Mid (8.9bn) 0 Aucune activité — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (8.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 Aucune activité — 0–15%
US Bruker Corp (BRKR)
Healthcare Services Mid (8.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (8.6bn) 0 Aucune activité — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (8.2bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (8.2bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (8.1bn) 0 Aucune activité — 0–15%
DK Demant A/S (DEMANT)
Healthcare Services Mid (8.1bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (8.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (8.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.8bn) -6–10 -$10M–$100M -0–15% 50%+
US Repligen Corp (RGEN)
Healthcare Services Mid (7.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) -1–5 -$1M–$10M -0–15% 0–15%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.6bn) 0 Aucune activité — 15–50%
US Glaukos Corp (GKOS)
Healthcare Services Mid (7.4bn) -1–5 -$1M–$10M -0–15% 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (7.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (7.2bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (7.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (7.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 50%+
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — —
US Arcellx Inc (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 Aucune activité — 0–15%
US Liquidia Corp (LQDA)
Pharmaceuticals & Medical Research Mid (6.7bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (6.4bn) 0 Aucune activité — 50%+
SE Sectra AB (SECT-B)
Healthcare Services Mid (6.4bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (6.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -< $100K -0–15% 0–15%
US R1 RCM Inc (RCM)
Healthcare Services Mid (6.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.9bn) -1–5 -$1M–$10M -0–15% 0–15%
US Chemed Corp (CHE)
Healthcare Services Mid (5.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.8bn) 0 Aucune activité — 0–15%
US Teleflex Inc (TFX)
Healthcare Services Mid (5.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.8bn) -1–5 -$10M–$100M -0–15% 0–15%